Health
FDA Recalls Over 11,000 Blood Pressure Pills
Health Points
- Over 11,000 bottles of bisoprolol fumarate and hydrochlorothiazide were recalled after trace contamination.
- The recall was initiated due to traces of a cholesterol medication found in some tablets.
- The FDA classified this as a low-risk (Class III) recall, but patients should consult their healthcare provider.
The FDA has announced a nationwide recall affecting thousands of bottles of a commonly prescribed blood pressure medication.
Bisoprolol fumarate and hydrochlorothiazide tablets by Glenmark Pharmaceuticals may contain small amounts of a different medication meant for cholesterol management.
The recall applies to 2.5 mg/6.25 mg tablets in sizes of 30, 100, and 500 count, associated with specific National Drug Codes and lot numbers expiring in late 2025 and mid-2026.
Identifying the Recalled Medication
Check your prescription for NDC 68462-878-30, 68462-878-01, or 68462-878-05, as well as lot codes 17232401 and 17240974 to see if your medication is affected.
If you take this recalled medication, do not make changes on your own, as stopping suddenly may pose health risks.
“While recall notifications can be frightening, it’s important to contact your healthcare provider right away for advice before making any changes to your medication routine,”
advised Jennifer Young, PharmD, BCPS, CSP, lead medication safety specialist at the Institute for Safe Medication Practices.
“Some medicines … should not be stopped suddenly.”
For additional questions, reach out to Glenmark’s customer service center or consult your pharmacist or healthcare provider.
Your health and medication safety are important—when in doubt, seek professional guidance before adjusting any treatment.
